Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2013	Dec. 31, 2012
Current Assets:
Cash	$ 534,418	$ 1,508,385
Trade accounts receivable less allowances of approximately $71,000 and $73,000, respectively	3,205,523	2,931,479
Receivables due from affiliated companies	618,275	556,051
Inventories, net	10,087,206	9,256,589
Prepaid expenses and other current assets	681,354	530,305
Deferred tax asset	91,496	56,221
Total Current Assets	15,218,272	14,839,030
Property, plant and equipment, net	5,273,714	5,327,909
Other Assets:
Trademarks, trade names and patents, net	806,332	819,194
Other assets	23,108	24,350
Total Other Assets	829,440	843,544
Total Assets	21,321,426	21,010,483
Current Liabilities:
Accounts payable - trade	1,556,373	1,431,457
Current portion of long term debt	409,964	407,095
Income taxes payable	153,731	65,944
Accrued expenses payable	731,630	913,129
Total Current Liabilities	2,851,698	2,817,625
Deferred tax liability	280,022	230,478
Long term debt, less current portion	1,428,659	1,532,286
Total Liabilities	4,560,379	4,580,389
Commitments and contingencies
Shareholders' Equity:
Common stock - $.01 par value, 12,000,000 shares authorized; 8,749,888 shares issued	87,499	87,499
Additional paid in capital	8,621,815	8,617,081
Less cost of common stock in treasury, 351,503 shares	(288,013)	(288,013)
Accumulated other comprehensive loss	(263,957)	(261,807)
Retained earnings	8,370,188	8,021,136
Total Shareholders' Equity of Ocean Bio-Chem, Inc.	16,527,532	16,175,896
Noncontrolling interest	233,515	254,198
Total Shareholders' Equity	16,761,047	16,430,094
Total Liabilities and Shareholders' Equity	$ 21,321,426	$ 21,010,483